Condition: Prostate Cancer · Sponsor: Varian, a Siemens Healthineers Company
This trial is a prospective, single-arm, multi-center clinical trial designed to assess whether adaptive radiotherapy with urethral sparing for low to intermediate risk localized prostate cancer will translate into a decreased rate of patient reported acute urinary side effects, as measured by the patient reported EPIC-26 questionnaire, compared with the historically reported rate for non-adaptive, non-urethral sparing prostate SBRT.
This description comes directly from the study's public registry record.
Sean Davidson, MASc · 1-437-991-8294 · sean.davidson@siemens-healthineers.com
Claire McCann, PhD · claire.mccann@siemens-healthineers.com
Always discuss trial participation with your own doctor first.
| Duarte Cancer Center | Duarte, California, United States | Recruiting |
| City of Hope Orange County Lennar Foundation Cancer Center | Irvine, California, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Active Not Recruiting |
| Washington University in St. Louis | St Louis, Missouri, United States | Recruiting |
| Fox Chase Cancer Center | Philadelphia, Pennsylvania, United States | Active Not Recruiting |
| Klinikum der Landeshauptstadt Stuttgart gKAöR | Stuttgart, Baden-Wurttemberg, Germany | Recruiting |
| Universitätsklinikum des Saarlandes (Saarland Univerisity Hospital) | Homburg, Saarland, Germany | Recruiting |
| Hospital Universitario de Navarra | Pamplona, Navarre, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05804318